Our results demonstrate that HNSC patients, both positive and negative for HPV presence, with high a RvD score presented longer disease-free survival, enhanced anti-tumor immunity mainly driven by CD8+ T cells, and transcriptional profiles predictive of a better response to ICI treatment. Here, CD8A is linked to neoplasm.